Novotna, Stanislava <br/><br/>
A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.  [electronic resource] 

 -  Clinical therapeutics  Mar 2014 
 - 357-67 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2014.01.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Sublingual<br/>Adult<br/>Aged<br/>Analgesics, Opioid--administration & dosage<br/>Breakthrough Pain--drug therapy<br/>Cross-Over Studies<br/>Disease Management<br/>Double-Blind Method<br/>Female<br/>Fentanyl--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Pain Management<br/>Pain Measurement<br/>Tablets